β-AR agonists are currently used as bronchodilators, tocolytic agents and chronotropic/inotropic agents, whereas β-AR antagonists or “β blockers” have revolutionized the treatment of a number of cardiovascular disorders including angina, hypertension, and heart failure [4,5]. The gene discussed is ADRB2; the disease is hypertensive disorder.